Inventor

EPSTEIN JOSEPH WILLIAM

US16 patents

⚠️ This page may combine multiple inventors who share the name “EPSTEIN JOSEPH WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WYETH CORP

6 patents

US6716862B2Apr 6, 2004

5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase

WYETH CORP3 citations60

US6784184B2Aug 31, 2004

5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase

WYETH CORP4 citations56

US6949661B2Sep 27, 2005

3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase

WYETH CORP0 citations52

US6861445B2Mar 1, 2005

3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase

WYETH CORP0 citations52

US6740675B2May 25, 2004

3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase

WYETH CORP0 citations52

US6605628B1Aug 12, 2003

Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase

WYETH CORP0 citations35

DOV PHARMACEUTICAL INC

5 patents

US6372919B1Apr 16, 2002

(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent

DOV PHARMACEUTICAL INC87 citations96

US6716868B2Apr 6, 2004

(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor

DOV PHARMACEUTICAL INC41 citations94

US7098230B2Aug 29, 2006

(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor

DOV PHARMACEUTICAL INC20 citations91

US7081471B2Jul 25, 2006

(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor

DOV PHARMACEUTICAL INC24 citations91

US7041835B2May 9, 2006

(−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor

DOV PHARMACEUTICAL INC23 citations91

AMERICAN CYANAMID CO

4 patents

US6204284B1Mar 20, 2001

Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies

AMERICAN CYANAMID CO154 citations96

US4088652AMay 9, 1978

Acylazabicyclohexanes

AMERICAN CYANAMID CO52 citations93

US4118417AOct 3, 1978

Process for resolving cis-1-substituted phenyl-1,2-cyclopropanedicarboxylic acids

AMERICAN CYANAMID CO46 citations92

US5968908AOct 19, 1999

Restricted 9-cis retinoids

AMERICAN CYANAMID CO15 citations69

DOV PHARMACEUTICALS INC

1 patent

US6569887B2May 27, 2003

(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake

DOV PHARMACEUTICALS INC41 citations92